PortfoliosLab logoPortfoliosLab logo
IPO Date
Jun 10, 2026

Highlights

Market Cap
CA$8.61B
Year Range
CA$26.05 - CA$40.18

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Apotex Health Corp

Performance

APTX.TO Performance Chart


Loading charts...

S&P 500 Index

Returns By Period


Apotex Health Corp

1D
0.88%
1M
28.43%
6M
YTD
1Y
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-1.01%
1M
-1.01%
6M
8.61%
YTD
11.67%
1Y
21.03%
3Y*
20.30%
5Y*
13.96%
10Y*
14.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

APTX.TO Monthly Returns History

Based on dividend-adjusted daily data since Jun 10, 2026, APTX.TO's average daily return is +1.16%, while the average monthly return is +16.01%. At this rate, an investment would double in approximately 0.4 years.

Historically, 100% of months were positive and 0% were negative. The best month was Jul 2026 with a return of +16.7%, while the worst month was Jun 2026 at 15.3%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 0 months.

On a daily basis, APTX.TO closed higher 67% of trading days. The best single day was Jun 26, 2026 with a return of +8.4%, while the worst single day was Jul 16, 2026 at -5.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202615.29%16.73%34.57%

Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Apotex Health Corp (APTX.TO) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APTX.TOBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

2.35

Martin ratioReturn relative to average drawdown

8.67

Dividends

Dividend History


Apotex Health Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Apotex Health Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Apotex Health Corp was 5.78%, occurring on Jul 16, 2026. The portfolio has not yet recovered.

The current Apotex Health Corp drawdown is 4.94%.


Drawdown

Fall

Recovery

Underwater

Related event

-5.78%Jul 2026
0s
3dJul 2026 - now
-3.96%Jun 2026
1d3d
4dJun 2026 - Jul 2026
-3.76%Jun 2026
1d2d
3dJun 2026 - Jun 2026
-3.57%Jun 2026
0s2d
2dJun 2026 - Jun 2026
-2.82%Jun 2026
0s1d
1dJun 2026 - Jun 2026

Drawdown Indicators


APTX.TOBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-5.78%

-48.87%

+43.09%

Max Drawdown (1Y)

Largest decline over 1 year

-9.17%

Max Drawdown (3Y)

Largest decline over 3 years

-19.59%

Max Drawdown (5Y)

Largest decline over 5 years

-23.14%

Max Drawdown (10Y)

Largest decline over 10 years

-27.97%

Current Drawdown

Current decline from peak

-4.94%

-2.43%

-2.51%

Average Drawdown

Average peak-to-trough decline

-1.57%

-9.63%

+8.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.48%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Apotex Health Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Apotex Health Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with APTX.TO

Add Apotex Health Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with APTX.TO